The study and treatment of the myelodysplastic patient
Sanz, M.A.; Bennett, J.M.; Vallespí, T.; Hoelzer, D.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion Suppl: 61-73
1994
ISSN/ISBN: 0034-8376 PMID: 7886312 Document Number: 432000
Document emailed within 1 workday
Related Documents
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097Saxena, A.; Saidman, B.; Greenwald, D.; Wasik, M.A. 1996: Testicular extramedullary myeloid cell tumor in a patient with myelodysplastic syndrome Archives of Pathology and Laboratory Medicine 120(4): 389-392
Yoshida, Y.; Oguma, S.; Uchino, H.; Maekawa, T.; Nomura, T. 1993: A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. a Japanese cooperative study International Journal of Clinical Pharmacology Research 13(1): 21-27
Fukuhara, T.; Miyake, T.; Maekawa, I.; Kurosawa, M.; Suzuki, S.; Noto, S.; Mori, A.; Chiba, K.; Toyoshima, T.; Hirano, T.; Morioka, M.; Tsutsumi, Y.; Okabe, M.; Kakinoki, Y. 2000: Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study International Journal of Hematology 71(4): 366-371
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Rohrberg, R.; Sternitzky, R. 1989: Hemorheologic study in myelodysplastic syndrome Folia Haematologica 116(1): 75-80
Prieto, F.; Carbonell, F.; Badía, L.; Castel, V.; Pérez Sirvent, M.L. 1985: Cytogenetics in the study of myelodysplastic syndromes Sangre 30(4-C): 669-679
Matsuda, M. 2007: Treatment for myelodysplastic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 1): 516-520
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Schrappe-Bächer, M.; Steffen, H.M.; Maier, M.; Bernards, P.; Hoeffken, A.; Fätkenheuer, G. 1990: Myelodysplastic syndrome--a retrospective study of 38 patients Medizinische Klinik 85(9): 511-516
Hellström-Lindberg, E. 1999: Treatment of adult myelodysplastic syndromes International Journal of Hematology 70(3): 141-154
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77
Krafft, T. 1988: Development and treatment of myelodysplastic syndrome Revue Medicale de la Suisse Romande 108(7): 571-572
Marisavljević, D.; Rolović, Z. 1992: Immunomorphometric study of megakaryocytes in patients with myelodysplastic syndrome Srpski Arhiv Za Celokupno Lekarstvo 120(11-12): 317-320
Uzuka, Y.; Saito, Y. 1989: Bestatin treatment of patients with myelodysplastic syndromes Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 1): 365-370
Cheson, B.D.; Zwiebel, J.A.; Dancey, J.; Murgo, A. 2000: Novel therapeutic agents for the treatment of myelodysplastic syndromes Seminars in Oncology 27(5): 560-577
Neuwirtová, R.; Steruská, M.; Lukásová, M.; Háber, J.; Cieslar, P.; Kvasnicka, J. 1987: Personal experience in the treatment of the myelodysplastic syndromes Vnitrni Lekarstvi 33(5): 453-462
Kamesaki, T.; Akifuji, Y.; Mori, M.; Ueki, J.; Nakamoto, S.; Kajii, E.; Ikemoto, S. 1993: A patient with Tn syndrome associated with myelodysplastic syndrome showed abnormal glycophorin B International Journal of Hematology 58(1-2): 113-118
Detmar, S.B.; Muller, M.J.; Wever, L.D.; Schornagel, J.H.; Aaronson, N.K. 2001: The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study JAMA 285(10): 1351-1357
Kizaki, M.; Koeffler, H.P. 1992: Differentiation-inducing agents in the treatment of myelodysplastic syndromes Seminars in Oncology 19(1): 95-105